McClarren Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

McClarren Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-302	Closed	-$66K	–	360
2024 Q4	$66K	Buy	+302	New	+$166K	0.19%	69
2024 Q3	–	Sell	-553	Closed	–	–	347
2024 Q2	$0	Buy	553 +551	+27,550%	+$316K	﹤0.01%	364
2024 Q1	$1K	Buy	2 +1	+100%	+$561	﹤0.01%	337
2023 Q4	$1K	Hold	1	–	–	﹤0.01%	361
2023 Q3	$0	Hold	1	–	–	﹤0.01%	397
2023 Q2	$0	Hold	1	–	–	﹤0.01%	462
2023 Q1	$0	Hold	1	–	–	﹤0.01%	457
2022 Q4	$0	Buy	+1	New	+$530	﹤0.01%	467

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

McClarren Financial Advisors's TMO Position: Q1 2025 in Review

McClarren Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 302 shares — an estimated $66K sold.

McClarren Financial Advisors first reported a position in TMO in Q4 2022 and held it in 8 quarters. The position peaked at $66K in Q4 2024. 2,570 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

McClarren Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
McClarren Financial Advisors sold 302 Thermo Fisher Scientific shares in Q1 2025, an estimated $66K.
McClarren Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 8 quarters.
McClarren Financial Advisors's Thermo Fisher Scientific position peaked at $66K in Q4 2024.
2,570 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on McClarren Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.